INSPECT Act
The INSPECT Act establishes independent oversight roles by requiring the President to appoint separate Inspectors General for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) within one year of the law's enactment. These Inspectors General will conduct audits and investigations to ensure accountability and integrity within each agency. The bill specifies that these positions will be funded using existing appropriations from the Department of Health and Human Services' Office of Inspector General, without requiring new federal funding. The law directly affects NIH, CDC, and FDA operations by adding dedicated oversight to their internal management processes.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2025
Committee Review
Floor Vote
President
Introduced May 6, 2025
Last action May 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 6, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
May 6, 2025
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Eric Schmitt
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1607
Scope: US
Hi! I can help you understand S 1607. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline